Unknown

Dataset Information

0

Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders.


ABSTRACT: B-cell chronic lymphoproliferative disorders (B-CLPD) comprise several entities with indolent clinical manifestations but heterogeneous survival. Cytogenetic aberrations are now the standard prognostic predictors in chronic lymphocytic leukemia (CLL) but have been less investigated in other subtypes of B-CLPD. In this study, we detected cytogenetic aberrations by fluorescence in situ hybridization (FISH) in 875 B-CLPD patients, based on a panel probes locating at 13q14, 11q22, 17p13 and CEP12. We identified del17p acted as the independent adverse cytogenetic predictor for overall survival (OS) in CLL. Del13q, del11q and del17p were adverse factors for OS in Waldenström's macroglobulinemia in the univariate analysis but lost their role in the multivariate analysis. Trisomy 12 acted as an independent poor factor for both marginal zone lymphoma (MZL) and unclassified B-CLPD (BCLPD-U) subtype. Del17p did not impact survival in MZL and BCLPD-U patients. These contrasting results indicate different roles of the same cytogenetic aberrations in the pathogenesis of each B-CLPD subtype. As del17p contributed to the poorest survival in CLL and desired extraordinary treatment strategy, the imitation of CLL strategy to other B-CLPD with del17p should be carefully advocated based on this study.

SUBMITTER: Yi S 

PROVIDER: S-EPMC5790468 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3886816 | biostudies-literature
| S-EPMC6166403 | biostudies-literature
| S-EPMC8584080 | biostudies-literature
| S-EPMC4767482 | biostudies-literature
| S-EPMC4962559 | biostudies-literature
| S-EPMC2674112 | biostudies-literature
| S-EPMC4176455 | biostudies-literature
| S-EPMC3471515 | biostudies-literature
| S-EPMC2756204 | biostudies-literature
| S-EPMC5122338 | biostudies-literature